Skip to content
Clinical ResearchResearch compoundLimited evidence

Adrafinil

Wakefulness-promoting substance, a prodrug of modafinil that the liver converts, so it acts more slowly; banned in competitive sport.

NootropicEugeroicEugeroicProdrugWakefulnessDopamineNorepinephrineSerotoninAnti-fatigue

Pharmacology

ClassEugeroic · Prodrug · Wakefulness
Primary targetModafinil (active metabolite)
Targets4 receptor targets
Half-life1 h (Adrafinil) → 12-15 h (Modafinil)
Onset60-90 min
EvidenceLimited evidence
Affected systemsDopamineNorepinephrineSerotoninAnti-fatigue

Contents

Related comparisons

Adrafinil vs Fladrafinil

DETAILED OVERVIEW

What is Adrafinil?

Adrafinil is a wakefulness-promoting substance and a prodrug of modafinil: the liver converts it into modafinil, so its effect is similar. It was once approved as a medicine in France for narcolepsy (a sleep disorder), but it was withdrawn from the market in 2011 for commercial reasons. Today it is sold without prescription as a research chemical in the European Union and as a supplement in the United States.

Because it first has to be converted, it starts working more slowly. Headache is a common side effect; it can also cause insomnia and anxiety, and it can moderately raise blood pressure and heart rate. With prolonged use liver enzyme levels can rise, so the risk is higher in liver disease; the official modafinil warning about severe skin reactions applies to adrafinil as well. It is contraindicated in pregnancy and breastfeeding, and it is a doping substance in competitive sport. Few human studies are available.

Mechanism

Modafinil prodrug, alpha-1 adrenergic

Half-life

1 h (Adrafinil) / 12-15 h (Modafinil)

Onset

60-90 min

Legal status

EU OTC research, USA OTC

Receptor profile

  • Modafinil (active metabolite)Strong
  • Dopamine transporterModerate
  • Orexin / histamine (wake systems)Moderate
  • LiverWeak

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Headache, common and often dose-dependent
  • Insomnia and disrupted sleep, especially with late dosing
  • Dry mouth, stomach discomfort, nausea
  • Anxiety, nervousness, irritability
  • Mild blood pressure rise and palpitations
  • Elevated liver enzymes (ALT/AST) with prolonged use
  • Reduced appetite

Contraindications · 6

  • Liver or kidney disease, higher risk due to hepatic conversion to modafinil, monitor LFTs
  • Pregnancy and breastfeeding
  • Serious cardiovascular disease, arrhythmia, unstable angina, uncontrolled hypertension
  • Modafinil hypersensitivity or history of severe skin reaction (Stevens-Johnson, DRESS)
  • Reduces hormonal contraceptive efficacy (CYP3A4 induction), use backup method
  • Avoid concurrent alcohol and other hepatotoxic drugs

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Adrafinil is a substance the liver converts into the well-known wakefulness-promoting drug Modafinil, so its effects are essentially similar to Modafinil's: it helps maintain alertness and concentration, and it was originally developed for narcolepsy-like conditions involving excessive fatigue. Its advantage is that it's available over the counter in some European regions where Modafinil requires a prescription, but the downside is a slower onset since the body first has to convert it.

Telegram

Have a question about Adrafinil?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC15H15NO3S
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.